Review
Open access
2026
Unveiling and harnessing: the tumor microenvironment in RAS/MAPK pathway-targeted therapy
Rational combination strategies are outlined that simultaneously target the RAS/MAPK axis and key TME vulnerabilities, such as immunotherapy combinations, CAF reprogramming, and ECM normalization, to overcome stromal-mediated resistance and achieve deeper, more sustained clinical responses.
Wen-Hao Ma, Xing-Yu Guo, Xiu-Ting Liu
· Cancer Advances · 0 citations